Back to Speakers

Jordan Johnson, MSHA

Jordan Johnson, MSHA

Chief Innovation Officer

Oncospark

Jordan Johnson, MSHA, iMPaCT is one of the nation's leading healthcare strategists with a focus on billing, coding, value, transparency, and compliance. He has over 12 years of advanced healthcare experience, with extensive experience in clinical, operational, and administrative oncology. He is a content expert in the Oncology RCM process and has served as an expert in litigation on the topic and policy creation. He also creates optimization and viability strategy based on data by associating cost to outcomes to influence operations. His transparency impact approaches have also been adopted by many leaders to increase staff engagement and shift culture. He has created several industry-leading software solutions, including analytic value identification and visualization tools. He is first and foremost a patient advocate and has served on many committees and drafted legislation to increase patient safety, quality, and value. His passion and resilience as an advocate drive from having a very personal connection to Cancer through the diagnosis, treatment and passing of both parents. Jordan does not believe in status quo in the current workflow, agenda, nor operations within cancer care. Rather he believes that healthcare and oncology models are changing and with the proper data-driven guidance, education, and analytics, one can ensure quality while maintaining financial and clinical viability. Though these changes will be challenging, they must be viewed as an opportunity. He is committed to putting action in defining value and quality. As a consultant, Mr. Johnson has tested the tools, education, theories, and integrations with 300+ clients for various strategic plans at rural facilities, systems/networks, payers, vendors, and providers. He is trusted by many to help lead the way for transformation to value-based Oncology care. His current work with price transparency has been featured by the Wall Street News Journal and is providing the framework for value-based oncology, viability, and access to care.